drugset / Trial / NCT03024255
A Confirmatory Safety and Efficacy Study of BBI-4000 in Subjects With Axillary Hyperhidrosis
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This study is being conducted to assess the safety and efficacy of 3 concentrations of BBI-4000 and vehicle (4 treatment arms), applied for the treatment of axillary hyperhidrosis.
Timeline
- Start
- 2016-12-22
- Primary completion
- 2017-09-19
- Completion
- 2017-09-19
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | SOFPIRONIUM | Small molecule | 5 % | Topical |
| Subject | SOFPIRONIUM | Small molecule | 10 % | Topical |
| Subject | SOFPIRONIUM | Small molecule | 15 % | Topical |